Concentra Group Holdings Parent Insider Thomas A. Devasia Sells $781K of Stock
Thomas A. Devasia sold 18,194 shares of Concentra Group Holdings Parent, Inc. at $42.92 a share, worth $781K in total on Nov 16, 2026. Shares held after the trade: 125,320 (-12.7%).
Concentra Group Holdings Parent Insider Greg M. Gilbert Sells $781K of Stock
Greg M. Gilbert sold 18,194 shares of Concentra Group Holdings Parent, Inc. at $42.90 a share, worth $781K in total on Nov 12, 2026. Shares held after the trade: 130,640 (-12.2%).
Concentra Group Holdings Parent Announces $33.4M Stock Buyback
Concentra Group Holdings Parent, Inc. entered into a privately negotiated stock repurchase agreement to buy back 800,000 shares of its common stock from board member Robert A. Ortenzio and related entities. The transaction was priced at $41.80 per share, totaling $33.44 million, representing a 1% discount to the market closing price. The buyback was executed under the company's existing share repurchase program and funded with cash on hand.
Concentra Group Holdings Parent Executive Compensation
Concentra Group Holdings Parent entered into amended and restated employment agreements for its executive leadership team following previously announced transitions. Matthew DiCanio's new agreement as President and CEO includes an annual base salary of $785,000 and a 125% target bonus, while William K. Newton's agreement as Executive Chairman provides for a $550,000 base salary and an 85% target bonus.
Concentra delivered a strong Q3 2026 beat-and-raise, driven by robust visit volumes and margin expansion, while successfully completing its multi-year separation from Select Medical.
Concentra Group Holdings Parent, Inc. reported a net income of $65.9 million for the quarter ended September 30, 2026, up from $48.3 million in the prior year period. Total revenue grew to $622.1 million for the quarter, while the company maintained a strong balance sheet with $3.01 billion in total assets and $126.5 million shares of common stock outstanding.
Concentra reported Q3 2026 revenue growth of 8.6% to $622.1 million and a 36.5% increase in net income attributable to the company. Alongside the results, the board authorized a new $250 million share repurchase program and declared a quarterly cash dividend of $0.0625 per share.
“Concentra delivered another strong quarter, reflecting the consistency of our operating model and the strength of our team. Over the past 50 years, we have built a market-leading occupational health company with a clear strategy for growth. With Matt assuming the CEO role, Concentra enters its next chapter with strong momentum, an experienced leadership team and significant opportunities to expand our reach and serve more employers and patients.”
Keith Newton, executive chairman of the Board
“Our third-quarter results demonstrate our ability to translate strong operating performance into profitable growth. We expanded our footprint, strengthened the balance sheet and returned capital to shareholders. The increase in full-year guidance reflects confidence in Concentra’s performance and continued momentum. Our focus remains on disciplined growth, operational excellence and delivering high-quality care while creating long-term value for customers, patients and shareholders.”
Matt DiCanio, president and chief executive officer